macrolides	are	antibiotic
lincosamides	are	antibiotic
streptogramins	are	antibiotic
macrolides	inhibit	bacterial protein synthesis
lincosamides	inhibit	bacterial protein synthesis
streptogramins	inhibit	bacterial protein synthesis
macrolides	bind	50S ribosomal subunit
lincosamides	bind	50S ribosomal subunit
streptogramins	bind	50S ribosomal subunit
macrolides	treat	respiratory infections
lincosamides	treat	anaerobic infections
streptogramins	treat	resistant infections
macrolides	cause	QT prolongation
lincosamides	cause	GI upset
streptogramins	cause	hepatotoxicity
macrolides	contraindicated	in pregnancy
lincosamides	contraindicated	in pregnancy
streptogramins	contraindicated	in pregnancy
macrolides	metabolized	CYP3A4
lincosamides	metabolized	hepatic
streptogramins	metabolized	hepatic
macrolides	interact with	statins
lincosamides	interact with	clindamycin
streptogramins	interact with	linezolid
macrolides	resistance	erm genes
lincosamides	resistance	lnu genes
streptogramins	resistance	vga genes
macrolides	synergy	with beta‑lactams
lincosamides	synergy	with clindamycin
streptogramins	synergy	with vancomycin
macrolides	used	macrolide‑resistant therapy
lincosamides	used	clindamycin therapy
streptogramins	used	quinupristin/dalfopristin
macrolides	side effect	rash
lincosamides	side effect	pseudomembranous colitis
streptogramins	side effect	thrombocytopenia
macrolides	dosage	oral
lincosamides	dosage	intravenous
streptogramins	dosage	intravenous
macrolides	half‑life	4–5 hours
lincosamides	half‑life	2–3 hours
streptogramins	half‑life	8–10 hours
macrolides	pharmacokinetics	high protein binding
lincosamides	pharmacokinetics	moderate protein binding
streptogramins	pharmacokinetics	high protein binding
macrolides	adverse	hepatotoxicity
lincosamides	adverse	nephrotoxicity
streptogramins	adverse	neurotoxicity
macrolides	monitoring	liver enzymes
lincosamides	monitoring	renal function
streptogramins	monitoring	platelet count
macrolides	indication	Mycoplasma pneumoniae
lincosamides	indication	Clostridioides difficile
streptogramins	indication	MRSA
macrolides	contraindication	severe liver disease
lincosamides	contraindication	severe renal disease
streptogramins	contraindication	severe hepatic disease
macrolides	drug‑drug	macrolide‑statin interaction
lincosamides	drug‑drug	clindamycin‑antibiotic interaction
streptogramins	drug‑drug	linezolid‑streptogramin interaction
macrolides	mechanism	23S rRNA binding
lincosamides	mechanism	23S rRNA binding
streptogramins	mechanism	50S subunit binding
macrolides	pharmacodynamics	time‑dependent
lincosamides	pharmacodynamics	concentration‑dependent
streptogramins	pharmacodynamics	concentration‑dependent
macrolides	dosing	weight‑based
lincosamides	dosing	weight‑based
streptogramins	dosing	weight‑based
macrolides	side effect	taste alteration
lincosamides	side effect	GI bleeding
streptogramins	side effect	rash
macrolides	use	prophylaxis
lincosamides	use	prophylaxis
streptogramins	use	prophylaxis
macrolides	resistance	efflux pumps
lincosamides	resistance	methylation
streptogramins	resistance	target modification
macrolides	monitoring	therapeutic drug levels
lincosamides	monitoring	therapeutic drug levels
streptogramins	monitoring	therapeutic drug levels
macrolides	adverse	bradycardia
lincosamides	adverse	hyperglycemia
streptogramins	adverse	hypotension
macrolides	indication	otitis media
lincosamides	indication	dental infections
streptogramins	indication	osteomyelitis
macrolides	contraindication	heart block
lincosamides	contraindication	heart block
streptogramins	contraindication	heart block
macrolides	drug‑drug	macrolide‑antifungal interaction
lincosamides	drug‑drug	lincosamide‑antifungal interaction
streptogramins	drug‑drug	streptogramin‑antifungal interaction
macrolides	side effect	photosensitivity
lincosamides	side effect	photosensitivity
streptogramins	side effect	photosensitivity
macrolides	pharmacokinetics	renal excretion
lincosamides	pharmacokinetics	renal excretion
streptogramins	pharmacokinetics	renal excretion
macrolides	synergy	with beta‑lactam antibiotics
